ARCHIVES

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007